The international PROGRESS registry of patients with severe sepsis: drotrecogin alfa (activated) use and patient outcomes

doi:10.1186/cc7936

Critical Care
Volume 13
Issue 3

Viewing options:

Abstract
Full text
PDF (233KB)
Additional files

Associated material:

PubMed record

Related literature:

Articles citing this article
on Google Scholar
on ISI Web of Science
on PubMed Central
Other articles by authors
on Google Scholar

Martin G
Brunkhorst FM
Janes JM
Reinhart K
Sundin DP
Garnett K
Beale R

on PubMed

Martin G
Brunkhorst FM
Janes JM
Reinhart K
Sundin DP
Garnett K
Beale R
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Nominate for award

Post to:

Research

The international PROGRESS registry of patients with severe sepsis: drotrecogin alfa (activated) use and patient outcomes

Greg Martin¹ , Frank M Brunkhorst² , Jonathan M Janes³ , Konrad Reinhart² , David P Sundin³ , Kassandra Garnett⁴ and Richard Beale⁵

¹Division of Pulmonary, Allergy, and Critical Care, Emory University, 615 Michael Street, Atlanta, Georgia, 30322, USA

²Department of Anesthesiology and Intensive Care, Friedrich Schiller University, Erlanger Allee 101, Jena, 07743, Germany

³Lilly Research Laboratories, Eli Lilly and Co., Lilly Corporate Center, Indianapolis, Indiana, 46285, USA

⁴i3 StatProbe, 1001 Winstead Drive, Cary, North Carolina, 27513, USA

⁵Intensive Care Unit, Guy's and St Thomas' Hospital, Lambeth Palace Road, London, SE1 7EH, UK

author email corresponding author email

Critical Care 2009, 13:R103doi:10.1186/cc7936


Published:	30 June 2009

Additional files

Additional file 1:

A word file containing a more detailed methodology of the propensity model development and a table (Table S1 in Additional data file 1) demonstrating the balance among baseline characteristics between the two treatment groups achieved in the propensity quartiles.

Format: DOCX Size: 26KB Download file